EAAA India Alternatives Ltd
NSE: EDELALTSCompany page on Cofacto
Open the EAAA India Alternatives Ltd page

EAAA India Alternatives Limited (EDELALTS) Q2 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

Cofacto Research Published November 06, 2026 5 min read

EAAA India Alternatives Limited (EDELALTS) is an alternatives asset manager with platforms including Sekura, AnZen, Citius TransNet, Viridis and Revinduz, and this is its first reporting quarter as a listed company after its Rs. 1,200-crore IPO. The print will speak to the fee-earning AUM bridge — net new fund closes versus ESOF III's full capital return — and the interim dividend decision on the Board agenda.

Quick Details
Results dateNovember 11, 2026
QuarterQ2 FY 2026-2027
Market capRs. 10,992.04 Cr
CMPRs. 1,700.1

EAAA India Alternatives Limited Q2 Results Date and Time

Per the November 5, 2026 intimation, a meeting of the Board of Directors of EAAA India Alternatives Limited is scheduled on Wednesday, November 11, 2026, to consider and approve the un-audited standalone and consolidated financial results of the company for the quarter and half-year ended September 30, 2026 (Q2 and H1 FY27), and to consider declaration of Interim Dividend, if any, on equity shares.

The earnings call to discuss Q2 and H1 FY27 results is scheduled for November 11, 2026, 4:00-5:00 PM IST, followed by Q&A. Dial-in numbers are +91 22 6280 1284 / +91 22 7115 8262, with international toll-free lines for Singapore, Hong Kong, USA and UK.

What to expect from EAAA India Alternatives Limited's Q2 FY27 results

This is EAAA India Alternatives' first results quarter since listing — the Rs. 1,200-crore all-OFS IPO priced at Rs. 1,665 closed October 28 and the shares listed on November 2, 2026 — so the Q2 package is the first read on the own-fund investment marks, net worth and fee-earning AUM lines that could not be pre-loaded from structured data.

The industry demand backdrop is a tailwind: SEBI data show total AIF commitments at Rs. 17.53 trillion as of June 2026, up 23.6% YoY, with Category III commitments up 36.9% YoY to Rs. 3.1 trillion in FY26.

Company-specific markers inside the window include ESOF III returning 100% of drawn investor capital after a Rs. 950-crore agrochemical exit, with roughly Rs. 8,700 crore realized across 15 of 17 investments; the Discovery private equity strategy scaled to about Rs. 2,500 crore in fee-paying AUM, and ESOF IV is in deployment toward its Rs. 13,500-crore target corpus.

A counterweight is that ESOF III's full capital return puts a late-lifecycle fund into run-off, so the AUM bridge hinges on whether Q2 saw net new closes net of that run-off. Rates turned into a headwind through the window — the 10-year G-sec yield broke 7% on September 11 and rose about 30 bps in September to about 7.20%, and just after quarter-close the October MPC hiked the repo rate 25 bps to 5.50% with a calibrated tightening stance.

The earnings call and results package are also the scheduled forums for disclosures the governance review could not verify, including Edelweiss-group related-party flows, sponsor ownership and encumbrances, SEBI/AIF status, and own-fund valuations.

Key Things To Watch

AUM and fee-earning AUM bridge: The first disclosed AUM picture as a listed company.

  • Net new fund closes versus ESOF III capital-return run-off — ESOF III has returned 100% of drawn investor capital after realizing about Rs. 8,700 crore across 15 of 17 investments
  • ESOF IV progress toward its Rs. 13,500-crore target corpus (launched December 2025)
  • Any single-fund or single-strategy concentration disclosure across Sekura, AnZen, Citius TransNet, Viridis and Revinduz; Discovery strategy at about Rs. 2,500 crore fee-paying AUM with Discovery Fund II at Rs. 1,300 crore raised

Own-fund valuation bridge: The write-down-sensitive balance-sheet line that could not be pre-loaded from data.

  • Mark-to-market moves or write-downs on balance-sheet investments in own funds, read against the 10-year G-sec yield rising about 30 bps in September to about 7.20%
  • Any fair-value-hierarchy changes in the own-fund valuation disclosure

SEBI and related-party Q&A: Pending disclosed regulatory items and group flows.

  • Status of the SEBI show cause notice dated July 12, 2024 to the company as sponsor/investment manager of Edelweiss Stressed and Troubled Assets Revival Fund Trust, and the May 2024 RBI cease-and-desist orders on ECL Finance and EARC — pending/unresolved as disclosed in the offer documents
  • Management's read on the July 14, 2026 AIF Regulations (Second Amendment) and the September 24, 2026 Board decision extending trust-form investor protections to all AIF structures
  • Edelweiss-group related-party flows, which the governance review could not verify from available documents

Interim dividend decision: A capital-allocation signal in the company's first quarter as a listed entity.

  • The November 11, 2026 Board agenda includes consideration of 'declaration of Interim Dividend, if any,' on equity shares — whether a dividend is declared will be clarified alongside the results

Frequently Asked Questions

What did EAAA's ESOF III fund achieve recently?

On July 24, 2026, EAAA announced that ESOF III, its Rs. 7,250-crore performing credit fund, had returned 100% of drawn investor capital after exiting a Rs. 950-crore agrochemical investment. That took the fund to roughly Rs. 8,700 crore realized across 15 of 17 investments, with two remaining and performing.

How is the Indian AIF industry's fundraising trend, EAAA's fee-base backdrop?

SEBI data show total AIF commitments at Rs. 17.53 trillion as of June 2026, up 23.6% YoY, with investments crossing Rs. 7 trillion for the first time. Category III AIF commitments grew 36.9% YoY to Rs. 3.1 trillion in FY26, outpacing the industry's 25.6% growth for a third straight year.

When did EAAA India Alternatives list on the stock exchanges?

The company's Rs. 1,200-crore all-OFS IPO, priced at Rs. 1,665, closed on October 28, 2026, and was subscribed 5.51x. The shares listed on November 2, 2026 at Rs. 1,673 on the BSE (+0.46%) and Rs. 1,675 on the NSE (+0.63%).

Are there any pending regulatory matters involving EAAA or its group entities?

As disclosed in the company's offer-document filings, a SEBI show cause notice dated July 12, 2024 relates to the company as sponsor/investment manager of Edelweiss Stressed and Troubled Assets Revival Fund Trust, and May 2024 RBI cease-and-desist orders apply to group companies ECL Finance and EARC. These items are pending/unresolved as disclosed, and no fresh order or show-cause notice surfaced in searches for the July-September 2026 window.

Disclaimer: This earnings preview is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings

Login Now